Back to Results
First PageMeta Content
McEwen Centre for Regenerative Medicine / Regenerative medicine / Stem cell / Stem Cell Network / Biology / Developmental biology / Biotechnology


DRIVING GLOBAL COMMERCIALIZATION CCRM IN REVIEW CCRM IN REVIEW 1
Add to Reading List

Document Date: 2013-12-16 11:00:10

Open Document

File Size: 4,13 MB

Share Result on Facebook

City

Toronto / /

Company

Cell Therapy Catapult / Cell Therapeutics / Merck KGaA / CCRM IN REVIEW / Ontario-China Stem Cell Partnership / CCRM / UK Cell Therapy Catapult Ontario / Toronto Life / PEOPLE 14 DEVELOPMENT FACILITY 16 DISCLOSURES 18 PARTNERS / Pfizer Canada / Regenerative Medicine Michael May / /

Continent

Asia / North America / Europe / /

Country

Canada / United Kingdom / China / North America / Europe / /

Currency

USD / /

EntertainmentAwardEvent

Commercialization Impact Prize / the McEwen-CCRM Commercialization Impact Prize / /

Event

Diplomatic Relations / Business Partnership / Company Expansion / /

Facility

University College London / University of Toronto / /

IndustryTerm

bioresorbable hydrogel technology / regenerative medicine products / stem cell banking / cell-based products / biomaterials-based products / Online Publishing Awards / business to business / technology development / manufacturing facilities / promising technologies / translational technology platforms / technology commercialization / regenerative medicine technologies / substantial network / therapeutic applications / foundational technologies / /

MedicalCondition

costly diseases / diseases / /

MedicalTreatment

cell therapy / /

Organization

University College London / McGill University’s Centre of Genomics and Policy / Pfizer-CCRM Innovation Fund / UK government / Strategic Advisory Board / Centre of Excellence for Commercialization and Research / Regenerative Medicine Coalition / Founders Advisory Board / Ethics Unit / McEwen Centre for Regenerative Medicine / Commercialization Review Committee / Government of Canada / Centre of Excellence / Ministry of Science and Technology / Centre for Commercialization / CC CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE / SickKids’ Transplant and Regenerative Medicine Centre / Ontario’s Ministry of Economic Development and Innovation / University of Toronto / MEDI’s Ontario China Research and Innovation Fund / Innovation Fund / /

Person

Andras Nagy / Gordon Keller / Centre / Chris Mason / Stanford Zandstra Rudnicki Sefton / Peter Zandstra / Derek van der Kooy / Thomas Waddell / Molly Shoichet / Ellis Keller Rossant Nagy Shoichet / /

Position

Chair / Board of Directors / ADVISORS / Chief Scientific Officer / leader / Professor / President and CEO / EXECUTIVE / Professor of Regenerative Medicine / /

ProvinceOrState

Ontario / /

PublishedMedium

Toronto Life / /

Technology

Genomics / transplantation / stem cells / manufacturing facilities Company incubation Contract research services Technology / versatile / bioresorbable hydrogel technology / drug screening / Out-licensing High value technologies / biomaterials / regenerative medicine technologies / RM technologies / REGENERATIVE MEDICINE / /

URL

www.ccrm.ca/rmnetwork / /

SocialTag